Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4

Cited by (329)

Items 101–200 of 329

1. Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity
   Giovanna Butera, Raffaella Pacchiana, Nidula Mullappilly, Marilena Margiotta, Stefano Bruno, Paola Conti, Chiara Riganti, Massimo Donadelli · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
2. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
   Dhanya K. Nambiar, Vandana Prajapati, Rajesh Agarwal, Rana Pratap Singh · 2012 · Cancer Letters
3. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi-directionally convert into cancer stem cells
   Elisa Dalla Pozza, Ilaria Dando, Giulia Biondani, Jessica Brandi, Chiara Costanzo, Elisa Zoratti, Matteo Fassan, Federico Boschi, Davide Melisi, Daniela Cecconi et al. · 2014 · International Journal of Oncology
4. Phosphorylation of CK1δ: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo
   Georgios Giamas, Heidrun Hirner, Levani Shoshiashvili, Arnhild Grothey, Susanne Gessert, Michael Kühl, Doris Henne‐Bruns, Constantinos E. Vorgias, Uwe Knippschild · 2007 · Biochemical Journal
5. The Tumor Suppressor KLF11 Mediates a Novel Mechanism in Transforming Growth Factor β–Induced Growth Inhibition That Is Inactivated in Pancreatic Cancer
   Anita Buck, Malte Buchholz, Martin Wagner, Guido Adler, Thomas Mathias Gress, Volker Ellenrieder · 2006 · Molecular Cancer Research
6. Keap1–Nrf2 signalling in pancreatic cancer
   Alastair J. Hayes, Christos Skouras, Beate Haugk, Richard Charnley · 2015 · The International Journal of Biochemistry & Cell Biology
7. Expression and Regulation of the Osteoarthritis-associated Protein Asporin
   Ikuyo Kou, Masahiro Nakajima, Shiro Ikegawa · 2007 · Journal of Biological Chemistry
8. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma
   Eseosaserea Igbinigie, Fengbiao Guo, Shi‐Wen Jiang, Cullen Kelley, Jinping Li · 2018 · Clinica Chimica Acta
9. New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions
   Susanne Klein‐Scory, Mahnaz Moradian Tehrani, Christina Eilert-Micus, Kamila A. Adamczyk, Nathalie Wojtalewicz, Martina Schnölzer, Stephan A. Hahn, Wolff Schmiegel, Irmgard Schwarte‐Waldhoff · 2014 · Proteome Science
10. Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs)
    Jan-Bart M. Koorstra, Georg Feldmann, Nils Habbe, Anirban Maitra · 2008 · Langenbeck s Archives of Surgery
11. p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth.
    Cédric Malicet, Nathalie Lesavre, Sophie Vasseur, Juan Iovanna · 2003 · Molecular Cancer
12. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells
    Lorenzo F. Sempere, Jason R. Gunn, Murray Korc · 2011 · Cancer Biology & Therapy
13. Radiosensitization by PARP inhibition to proton beam irradiation in cancer cells
    Takahisa Hirai, Soichiro Saito, Hiroaki Fujimori, Keiichiro Matsushita, Teiji Nishio, Ryuichi Okayasu, Mitsuko Masutani · 2016 · Biochemical and Biophysical Research Communications
14. PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer
    Tânia D. F. Costa, Ting Zhuang, Julie Lorent, Emilia Turco, Helene Olofsson, Míriam Masià-Balagué, Miao Zhao, Parisa Rabieifar, Neil Robertson, Raoul Kuiper et al. · 2019 · Nature Communications
15. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK
    FENG-PING PAN, Hongkun Zhou, Heqi Bu, Kai Chen, Hao Zhang, LU-PING XU, Jian Tang, QING-JIANG YU, Yongquan Chu, JIE PAN et al. · 2016 · Oncology Reports
16. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice
    Junpei Yamaguchi, Mari A. Mino-Kenudson, Andrew Scott Liss, Sanjib Chowdhury, Timothy Cragin Wang, Carlos F. Fernandez-del Castillo, Keith D. Lillemoe, Andrew Louis Warshaw, Sarah P. Thayer · 2016 · Gastroenterology
17. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
    Michael Eyres, Simone Lanfredini, Haonan Xu, Adam Burns, Andrew Blake, Frances W. Willenbrock, Robert David Goldin, Daniel Llwyd Hughes, Sophie L. Hughes, Asmita Thapa et al. · 2021 · Gastroenterology
18. The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential
    Kim, SangWun, Lahmy, Reyhaneh, Riha, Chelsea, Yang, Challeng, Jakubison, Brad L., van Niekerk, Jaco, Staub, Claudio, Wu, Yifan, Gates, Keith, Dong, Duc Si et al. · 2015 · Pancreas
19. Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures
    Fuuka Minami, Norihiko Sasaki, Yuuki Shichi, Fujiya Gomi, Masaki Michishita, Kozo Ohkusu‐Tsukada, Masashi Toyoda, Kimimasa Takahashi, Toshiyuki Ishiwata · 2021 · Scientific Reports
20. The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models
    Gioia Cherubini, Cecilia Kallin, A Mozetic, K Hammaren-Busch, H Müller, Nicholas Robert Lemoine, Gunnel Halldén · 2011 · Gene Therapy
21. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation
    Lionel Chia, Bowen Wang, Jung‐Hyun Kim, Li Luo, Shuai Shuai, Iliana Herrera, Sophia Y. Chen, Liping Li, Lingling Xian, Tait H Huso et al. · 2023 · Journal of Clinical Investigation
22. Bone morphogenetic protein −4 and −5 in pancreatic cancer—Novel bidirectional players
    Siru Virtanen, Emma‐Leena Alarmo, Saana Sandström, Minna Ampuja, Anne H. Kallioniemi · 2011 · Experimental Cell Research
23. Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair
    Wang Zheng, Songtao Lai, Ningyi Ma, Yun Deng, Yong Liu, Dongping Wei, Jian-Dong Zhao, Guo-Liang Jiang · 2015 · Cancer Letters
24. Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells
    Steven L. Warner, Rubén M. Muñoz, Phillip Stafford, Erich Koller, Laurence H. Hurley, Daniel D. Von Hoff, Haiyong Han · 2006 · Molecular Cancer Therapeutics
25. Disclosure of Erlotinib as a Multikinase Inhibitor in Pancreatic Ductal Adenocarcinoma
    Laura Conradt, Klaus Godl, Christoph Schaab, Andreas Tebbe, Stefan Eser, Sandra Diersch, Christoph W. Michalski, Jorg H. Kleeff, Angelika Schnieke, Roland Michael Schmid et al. · 2011 · Neoplasia
26. Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro
    Shannon F. Kostin, Debbie E. McDonald, David Wayne McFadden · 2012 · Journal of Surgical Research
27. An oncolytic adenovirus defective in pRb-binding (dl922–947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine
    Madhumita Bhattacharyya, Jennelle Francis, A Eddouadi, Nicholas Robert Lemoine, Gunnel Halldén · 2011 · Cancer Gene Therapy
28. Intracellular zinc increase inhibits p53−/− pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis
    Massimo Donadelli, Elisa Dalla Pozza, Maria Teresa Scupoli, C. Costanzo, Aldo Scarpa, Marta Palmieri · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
29. Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
    James A. Butz, Eric Wickstrom, Jeremy S. Edwards · 2003 · BMC Biotechnology
30. Pathology Analysis Reveals That Dysplastic Pancreatic Ductal Lesions Are Frequent in Patients With Hereditary Pancreatitis
    Vinciane Rebours, Philippe Lévy, Jean‐François Mosnier, Jean‐Yves Scoazec, Marie–Sophie Soubeyrand, Jean–François Fléjou, Bruno Turlin, Pascal R. Hammel, Philippe B Ruszniewski, Pierre Bédossa et al. · 2009 · Clinical Gastroenterology and Hepatology
31. SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo
    Monica Cattaneo, Simonetta Orlandini, Stefania Beghelli, Patrick S. Moore, Claudio Sorio, Antonio Bonora, Claudio Bassi, Giorgio Talamini, Giuseppe Zamboni, Rosaria Orlandi et al. · 2003 · Oncogene
32. Synergistic effect of trichostatin A and 5‐aza‐2′‐deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: A proteomic study
    Daniela Cecconi, Massimo Donadelli, Elisa Dalla Pozza, Sara Rinalducci, Lello Zolla, Maria Teresa Scupoli, Pier Giorgio Righetti, Aldo Scarpa, Marta Palmieri · 2009 · PROTEOMICS
33. Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy
    Vladia Monsurrò, Stefania Beghelli, Richard Wang, Stefano Barbi, Silvia Coin, Giovanni Di Pasquale, Samantha Bersani, Monica Castellucci, Claudio Sorio, Stefano Eleuteri et al. · 2010 · Journal of Translational Medicine
34. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma
    N. Lehnen, A. von Mässenhausen, H. Kalthoff, Hui Zhou, T. Glowka, Ute Schütte, T. Höller, K. Riesner, D. Boehm, S. Merkelbach-Bruse et al. · 2013 · Histopathology
35. The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation
    Elisabeth Jahny, Hai Yang, Bin Liu, Beatrix Jahnke, Franziska Lademann, Thomas Knösel, Petra Rümmele, Robert Grützmann, Daniela Ellen Aust, Christian P. Pilarsky et al. · 2017 · PLoS ONE
36. External Qi of Yan Xin Qigong differentially regulates the Akt and extracellular signal-regulated kinase pathways and is cytotoxic to cancer cells but not to normal cells
    Xin Yan, Hua Min Shen, Hongjian Jiang, Chengsheng Zhang, Dan Hu, Jun Wang, Xinqi Wu · 2006 · The International Journal of Biochemistry & Cell Biology
37. Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model
    Jodee L. Johnson, Vermont P. Día, Matthew A. Wallig, Elvira González de Mejı́a · 2014 · Pancreas
38. Identification of SMURF1 as a possible target for 7q21.3‐22.1 amplification detected in a pancreatic cancer cell line by in‐house array‐based comparative genomic hybridization
    Ayako Suzuki, Tatsuhiro Shibata, Yutaka Shimada, Yoshinori Murakami, Akira Horii, Keiko Shiratori, Setsuo Hirohashi, Johji Inazawa, Issei Imoto · 2008 · Cancer Science
39. Modeling Pancreatic Cancer In Vivo
    Yongzeng Ding, John D. Cravero, Kevin Adrián, Paul J. Grippo · 2010 · Pancreas
40. Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes
    Massimo Donadelli, Elisa Dalla Pozza, C. Costanzo, Maria Teresa Scupoli, Aldo Scarpa, Marta Palmieri · 2007 · Journal of Cellular Biochemistry
41. Modeling Pancreatic Cancer in Animals to Address Specific Hypotheses
    Paul J. Grippo, Eric P. Sandgren · 2004 · Humana Press eBooks
42. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice
    Shinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, Hiroko Shindo, Ei Takahashi, Sumio Hirose, Shinya Maekawa, Kunio Mochizuki, Hiromichi Kawaida, Jun Itakura et al. · 2017 · Pancreas
43. A Histone Methylation–MAPK Signaling Axis Drives Durable Epithelial–Mesenchymal Transition in Hypoxic Pancreatic Cancer
    Brooke A. Brown, Paul J. Myers, Sara J. Adair, Jason Robert Pitarresi, Shiv K. Sah‐Teli, Logan A. Campbell, William S. Hart, Michelle C. Barbeau, Kelsey M. Leong, Nicholas M. Seyler et al. · 2024 · Cancer Research
44. Anti-Pancreatic Cancer Effects of a Polar Extract From the Edible Sea Cucumber, Cucumaria frondosa
    Alexandra B. Roginsky, Xianzhong Ding, Carl Woodward, Michael B. Ujiki, Brahmchetna Singh, Richard H. Bell, Peter D. Collin, Thomas Edward Adrian · 2010 · Pancreas
45. Emerging molecular biology of pancreatic cancer.
    Ralph H. Hruban, Anirban Maitra, Richard David Schulick, Daniel A. Laheru, Joseph Herman, Scott E. Kern, Michael Goggins · 2008 · PubMed Central
46. Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells
    Alessia Di Florio, Laura Adesso, Simona Pedrotti, Gabriele Capurso, Emanuela Pilozzi, Vincenzo Corbo, Aldo Scarpa, Raffaele Geremia, Gianfranco Delle Fave, Claudio Sette · 2011 · Endocrine Related Cancer
47. Role of keratan sulfate expression in human pancreatic cancer malignancy
    Premila Devi Leiphrakpam, Prathamesh P. Patil, Neeley A. Remmers, Benjamin J. Swanson, Paul M. Grandgenett, Fang Qiu, Fang Yu, Prakash Radhakrishnan · 2019 · Scientific Reports
48. Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
    Beate Gündel, Xinyuan Liu, Matthias J. Löhr, Rainer Lothar Heuchel · 2021 · Frontiers in Cell and Developmental Biology
49. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1
    Daniela Basso, Dania Bozzato, Andrea Padoan, Stefania Moz, Carlo‐Federico Zambon, Paola Fogar, Eliana Greco, Michele Scorzeto, Francesca Simonato, Filippo Navaglia et al. · 2014 · Cell Communication and Signaling
50. Transcription Inhibition of Oncogenic KRAS by a Mutation-Selective Peptide Nucleic Acid Conjugated to the PKKKRKV Nuclear Localization Signal Peptide
    Susanna Cogoi, Andrea Codognotto, Valentina Rapozzi, Nico J. Meeuwenoord, G. van der Marel, Luigi Emilio Xodo · 2005 · Biochemistry
51. Animal Models
    Jami L. Saloman, Kathryn M. Albers, Zobeida Cruz‐Monserrate, Brian M. Davis, Mouad Edderkaoui, Guido Eibl, Ariel Y. Epouhe, Jeremy Y. Gedeon, Fred S. Gorelick, Paul J. Grippo et al. · 2019 · Pancreas
52. NOP14 promotes proliferation and metastasis of pancreatic cancer cells
    Bin Zhou, Qiao Wu, Ge Chen, Taiping Zhang, Yu-Pei Zhao · 2012 · Cancer Letters
53. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels
    Kaidi Mikhitarian, Maressa Pollen, Zhiguo Zhao, Yu Shyr, Nipun B. Merchant, Alexander A. Parikh, Frank L. Revetta, Mary Kay Washington, Cindy L. Vnencak‐Jones, Chanjuan Shi · 2013 · Modern Pathology
54. Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells
    Claudia Di Carlo, Bebiana C. Sousa, Marcello Manfredi, Jessica Brandi, Elisa Dalla Pozza, Emílio Marengo, Marta Palmieri, Ilaria Dando, Michael J.O. Wakelam, Andrea F. Lopez‐Clavijo et al. · 2021 · Scientific Reports
55. Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives
    Elisa Dalla Pozza, Massimo Donadelli, Chiara Costanzo, Tatyana Zaniboni, Ilaria Dando, Marta Franchini, Silvia Arpicco, Aldo Scarpa, Marta Palmieri · 2011 · Free Radical Biology and Medicine
56. Increased stability of P21WAF1/CIP1 mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate
    Massimo Donadelli, Elisa Dalla Pozza, Chiara Costanzo, Maria Teresa Scupoli, Paolo Piacentini, Aldo Scarpa, Marta Palmieri · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
57. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
    Javier Martínez‐Useros, Jesús García‐Foncillas · 2016 · BioMed Research International
58. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model
    Haiji Bo, Li Gao, Ying Chen, Jing Zhang, Ming-hua Zhu · 2015 · Molecular Medicine Reports
59. Role of TFEB-driven autophagy regulation in pancreatic cancer treatment
    Kathrin Klein, Kristin Werner, Christian Teske, Miriam Schenk, Thomas Giese, Jürgen Weitz, Thilo Welsch · 2016 · International Journal of Oncology
60. SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H‐1PV
    Sebastian Dempe, Alexandra Stroh-Dege, Elisabeth Schwarz, Jean Rommelaere, Christiane Dinsart · 2009 · International Journal of Cancer
61. High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells
    Meredith C. Henderson, Irma M. Gonzales, Shilpi Arora, Ashish Kumar Choudhary, Jeffrey M. Trent, Daniel D. Von Hoff, Spyro Mousses, David O. Azorsa · 2011 · Molecular Cancer Research
62. Vulpinic acid contributes to the cytotoxicity of Pulveroboletus ravenelii to human cancer cells by inducing apoptosis
    Sil Kim, Hae Min So, Hyun‐Soo Roh, Jin Kim, Jae Sik Yu, Seul Lee, Soon‐Ja Seok, Changhyun Pang, Kwan‐Hyuck Baek, Ki Hyun Kim · 2017 · RSC Advances
63. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)
    Mehdi Ouaïssi, Françoise Silvy, Costa Lima Sofia, Urs Giger-Pabst, Zemmour Kevin, Bernard Sastre, Igor Sielezneff, Anabela Cordeiro‐da‐Silva, Dominique Lombardo, Eric Mas et al. · 2012 · Pancreatology
64. 5‐Fluorouracil or gemcitabine combined with adenoviral‐mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc‐1 pancreatic adenocarcinoma cells
    Christopher Michael Halloran, Paula Ghaneh, Susannah Shore, William Greenhalf, Lou Zumstein, Deborah Wilson, John P. Neoptolemos, Eithne Costello · 2004 · The Journal of Gene Medicine
65. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines
    Sven Eisold · 2004 · World Journal of Gastroenterology
66. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
    Erin L. Wuebben, Phillip J. Wilder, Jesse L. Cox, James A. Grunkemeyer, Thomas C. Caffrey, Michael Anthony Hollingsworth, Angie Rizzino · 2016 · Oncotarget
67. Narrow line between benefit and harm: Additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells
    Vaidotas Čėsna, Artūras Sukovas, Aldona Jasukaitienė, Rima Naginienė, Giedrius Barauskas, Žilvinas Dambrauskas, Saulius Paškauskas, Antanas Gulbinas · 2018 · World Journal of Gastroenterology
68. BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis
    Christina A. Wicker, Ravi P. Sahu, Kashmira S. Kulkarni-Datar, Sanjay Srivastava, Thomas L. Brown · 2009 · Cancer Growth and Metastasis
69. RETRACTED ARTICLE: Oncolysis of pancreatic tumour cells by a γ34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway
    Federica Sarinella, Arianna Calistri, Paola Sette, Giorgio Palù, Cristina Parolin · 2006 · Gene Therapy · Retracted
70. Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint
    Matthew Thomas Huggett, Slavica Tudzarova, Ian Proctor, Marco Loddo, Margaret Geraldine Keane, Kai Stoeber, Gareth Haydn Williams, Stephen P. Pereira · 2016 · Oncotarget
71. New developments in the early diagnosis of pancreatic cancer
    Qiubo Zhang, ShaoJie Chen, Linjuan Zeng, Yinting Chen, Guoda Lian, Chenchen Qian, Jiajia Li, Ruijie Xie, Kaihong Huang · 2016 · Expert Review of Gastroenterology & Hepatology
72. Rapid and quantitative method for evaluating the personal therapeutic potential of cancer drugs
    Atsushi Kosaihira, Toshihiro Ona · 2008 · Analytical and Bioanalytical Chemistry
73. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: An in vitro and in vivo study
    Bence Sipos, Dirk Weber, Hendrik Ungefroren, Holger Kalthoff, Andre Zühlsdorff, Claudia Luther, Virág Török, Günter Klöppel · 2002 · International Journal of Cancer
74. Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures
    Yuuki Shichi, Fujiya Gomi, Norihiko Sasaki, Keisuke Nonaka, Tomio Arai, Toshiyuki Ishiwata · 2022 · Journal of Personalized Medicine
75. In vitromodels of pancreatic cancer for translational oncology research
    Georg Feldmann, Sherri L. Rauenzahn, Anirban Maitra · 2009 · Expert Opinion on Drug Discovery
76. Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
    Peng Wang, Yi-Chen Sun, Wen-Hua Lu, Peng Huang, Yumin Hu · 2015 · 癌症：英文版
77. Cystathionine β-synthase overexpression drives metastatic dissemination in pancreatic ductal adenocarcinoma via inducing epithelial-to-mesenchymal transformation of cancer cells
    Ágnes Czikora, Katalin Erdélyi, Tamás Ditrói, Noémi Szántó, Eszter Petra Jurányi, Szilárd Szanyi, József Tóvári, Tamás Strausz, Péter Nagy · 2022 · Redox Biology
78. The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines
    Ravi P. Sahu, Sanjay Batra, Prabodh K. Kandala, Thomas L. Brown, Sanjay Srivastava · 2010 · Cancer Chemotherapy and Pharmacology
79. Terminally Modified Oligodeoxynucleotides Directed Against p53 in an Orthotopic Xenograft Model: A Novel Adjuvant Treatment Strategy for Pancreatic Ductal Carcinoma
    Jürgen Tepel, Marie‐Luise Kruse, Christina March, Alexander Fiedler, Matthias Kapischke, Thomas Ketterer, Bence Sipos, B. Kremer, Holger Kalthoff · 2003 · Pancreas
80. Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells
    Hao Zhang, LIANG CHEN, Heqi Bu, QING-JIANG YU, Dandan Jiang, FENG-PING PAN, YU WANG, DIAN-LEI LIU, Shengzhang Lin · 2015 · Oncology Reports
81. Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells
    Immacolata Maietta, Amparo Martínez-Pérez, Rosana Álvarez, Ángel R. de Lera, África González‐Fernández, Rosana Simón‐Vázquez · 2022 · Pharmaceuticals
82. Integrative genomic and functional profiling of the pancreatic cancer genome
    Alan Hunter Shain, Keyan Salari, Craig P. Giacomini, Jonathan R. Pollack · 2013 · BMC Genomics
83. Molecular prognostic factors in patients with pancreatic cancer
    Giuseppe Tonini, Francesco Pantano, Bruno Vincenzi, Armando Gabbrielli, Roberto Coppola, Daniele Santini · 2007 · Expert Opinion on Therapeutic Targets
84. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
    Jingjing Lu, Bhaskar Roy, Marlys A. Anderson, Cadman L. Leggett, Michael J. Levy, Brian W. Pogue, Tayyaba G. Hasan, Kenneth K. Wang · 2019 · Journal of Biomedical Optics
85. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases
    Yue-Xin Ren, Guo-Ming Xu, Zhaoshen Li, Yu-gang Song · 2004 · World Journal of Gastroenterology
86. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
    Tina Daunke, Silje Beckinger, Sascha Rahn, Sandra Krüger, Steffen Markus Heckl, H. Schäfer, Daniela Wesch, Christian P. Pilarsky, Markus Eckstein, Arndt Hartmann et al. · 2023 · Frontiers in Immunology
87. Role of Hypermethylation on Carcinogenesis in the Pancreas
    Tamotsu Kuroki, Yoshitsugu Tajima, Takashi Kanematsu · 2004 · Surgery Today
88. Patterns of K‐ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing
    Shuanzeng Wei, Zhiyong Liang, Jie Gao, Shafei Wu, Zhu Hong, Hongrui Liu, Tonghua Liu · 2004 · Journal of Gastroenterology and Hepatology
89. The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
    Constantia Pantelidou, Gioia Cherubini, Nicholas Robert Lemoine, Gunnel Halldén · 2016 · Oncotarget
90. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
    Takeshi Matsumoto, Takashi Komori, Yuta Yoshino, Tadaaki Ioroi, Tsukasa Kitahashi, Hiromu Kitahara, Kohei Ono, Tamami Higuchi, Masayo Sakabe, Hiroshi Kori et al. · 2021 · Pharmaceutical Research
91. Proteomic Analysis of Pancreatic Ductal Carcinoma Cells after Combined Treatment with Gemcitabine and Trichostatin A
    Daniela Cecconi, Massimo Donadelli, Aldo Scarpa, Alberto Milli, Marta Palmieri, Mahmoud H. Hamdan, Liliana B. Areces, Juri Rappsilber, Pier Giorgio Righetti · 2005 · Journal of Proteome Research
92. Human platelet lysate as validated replacement for animal serum to assess chemosensitivity
    Miriam Pons · 2018 · ALTEX
93. Development of Signaling Echo Method for Cell-based Quantitative Efficacy Evaluation of Anti-cancer Drugs in Apoptosis without Drug Presence Using High-precision Surface Plasmon Resonance Sensing
    Hiroshi Nishijima, Atsushi Kosaihira, Junko Shibata, Toshihiro Ona · 2010 · Analytical Sciences
94. NPTX2 Hypermethylation in Pure Pancreatic Juice Predicts Pancreatic Neoplasms
    Fan Yao, Jing Qi Feng, Bo Chen, Huimian Xu, Shubao Wang, Mingjun Sun, Ming Dong · 2013 · The American Journal of the Medical Sciences
95. Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27KIP1/pRB pathway
    Hyun‐Jung An, Mihyeun Ryu, Hye Jin Jeong, Minho Kang, Hyung-Min Jeon, Jie‐Oh Lee, Young Sang Kim, Hayyoung Lee · 2019 · Cancer Letters
96. αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model
    Melis Debreli Coskun, Thangirala Sudha, Dhruba Jyoti Bharali, Serap Çelikler, Paul J. Davis, Shaker A. Mousa · 2020 · Frontiers in Pharmacology
97. RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
    Eliana Amato, Stefano Barbi, Matteo Fassan, Claudio Luchini, Caterina Vicentini, Matteo Brunelli, Giuseppe Malleo, Aldo Scarpa, Giorgio Malpeli · 2016 · BMC Cancer
98. Molecular beacon imaging of tumor marker gene expression in pancreatic cancer cell
    Lily P H Yang, Zehong Cao, Yiming Lin, William C. Wood, Charles A. Staley · 2005 · Cancer Biology & Therapy
99. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer
    Shinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, Hiroko Shindo, Ei Takahashi, Sumio Hirose, Yoshimitsu Fukasawa, Satoshi Kawakami, Hiroshi Hayakawa, Shinya Maekawa et al. · 2019 · Pancreas
100. Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion
     Claudio Sorio, Paola Capelli, Daniele Lissandrini, Patrick S. Moore, Piera Balzarini, Massimo Falconi, Giuseppe Zamboni, Aldo Scarpa · 2005 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin